Bordetella pertussis, Finland and France

Caro, Valérie; Elomaa, Annika; Brun, Delphine; Mertsola, Jussi; He, Qiushui; Guiso, Nicole

Back to Previous Page

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Bordetella pertussis, Finland and France

Published Date:

Jun 2006

Source:

Emerg Infect Dis. 12(6):987-989.

[PDF - 131.31 KB]

Details:

Personal Authors:

Caro, Valérie ; Elomaa, Annika ; Brun, Delphine ; Mertsola, Jussi ; He, Qiushui ; ... More ▼

Keywords:

[+]

Description:

We used pulsed-field gel electrophoresis analysis and genotyping to compare clinical isolates of Bordetella pertussis recovered since the early 1990s in Finland and France, 2 countries with similar histories of long-term mass vaccination with whole-cell pertussis vaccines. Isolates from both countries were similar genetically but varied temporally.

Document Type:

Journal Article

Collection(s):

Emerging Infectious Diseases

Supporting Files:

05-1283-F.gif	image/gif
05-1283-F.jpg	image/jpeg
05-1283-FA1.gif	image/gif
05-1283-FA1.jpg	image/jpeg
05-1283.nxml	text/plain
license.txt	text/plain

No Related Documents.

You May Also Like:

Bordetella pertussis Isolates, Finland

Personal Author:

Mäkinen, Johanna; Mertsola, Jussi; Mooi, Frits R.; Van Amersfoorth, Shirley; Arvilommi, Heikki; Viljanen, Matti K.; He, Qiushui;

Published:

Jan 2005

Source:

Emerg Infect Dis. 11(1):183-184.

File Type:

[PDF - 35.22 KB]
Macrolide-Resistant Bordetella pertussis Infection in Newborn Girl, France

Personal Author:

Guillot, Sophie; Descours, Ghislaine; Gillet, Yves; Etienne, Jérome; Floret, Daniel; Guiso, Nicole;

Published:

Jun 2012

Source:

Emerg Infect Dis. 18(6):966-968.

Description:

A macrolide antimicrobial drug was administered to a newborn with cough. On day 23 of hospitalization, macrolide-resistant Bordetella pertussis was isolated from nasopharyngeal aspirates. DNA sequencing and PCR-restriction fragment length polymorphis...

File Type:

[PDF - 276.65 KB]
Virulence of Pertactin-Negative Bordetella pertussis Isolates from Infants, France

Personal Author:

Bodilis, Hélène; Guiso, Nicole;

Published:

Mar 2013

Source:

Emerg Infect Dis. 19(3):471-474.

Description:

Bordetella pertussis isolates that do not express pertactin (PRN) are increasing in regions where acellular pertussis vaccines have been used for >7 years. We analyzed data from France and compared clinical symptoms among infants <6 months old infect...

File Type:

[PDF - 3.59 MB]
Bordetella pertussis Strain Lacking Pertactin and Pertussis Toxin

Personal Author:

Williams, Margaret M.; Sen, Kathryn; Weigand, Michael R.; Skoff, Tami H.; Cunningham, Victoria A.; Halse, Tanya A.; Tondella, M. Lucia;

Corporate Author:

CDC Pertussis Working Group

Published:

Feb 2016

Source:

Emerg Infect Dis. 22(2):319-322.

Description:

A Bordetella pertussis strain lacking 2 acellular vaccine immunogens, pertussis toxin and pertactin, was isolated from an unvaccinated infant in New York State in 2013. Comparison with a French strain that was pertussis toxin-deficient, pertactin wil...

File Type:

[PDF - 371.16 KB]
Complete Genome Sequences of Bordetella pertussis Vaccine Reference Strains 134 and 10536

Personal Author:

Weigand, Michael R.; Peng, Yanhui; Loparev, Vladimir; Batra, Dhwani; Burroughs, Mark; Johnson, Taccara; Juieng, Phalasy; Rowe, Lori; Tondella, M. Lucia; Williams, Margaret M.;

Published:

Sep 15 2016

Source:

Genome Announc. 2016; 4(5).

Description:

Vaccine formulations and vaccination programs against whooping cough (pertussis) vary worldwide. Here, we report the complete genome sequences of two divergent Bordetella pertussis reference strains used in the production of pertussis vaccines.

File Type:

[PDF - 142.45 KB]